Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 15 | Colson Nathaniel HOfficer EVP, CFO & CRO | Open-market sale · 10b5-1 plan | SELL | $542K 20.0K sh |
| Jun 26, 2026 traded Jun 25, 2026 |
| 15 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $309K 999 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 15 | Syphax Scott CDirector | Disposition to issuer | D | $630K 25.2K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 15 | Galla Christopher TSVP, GC, and Corp. Secretary | Open-market sale · 10b5-1 plan | SELL | $268K 2,333 sh | Jun 26, 2026 traded Jun 26, 2026 |
| 14 | Venker EricPresident & Immunovant CEO | Open-market sale · 10b5-1 plan | SELL | $5.08M 153.8K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 14 | Seymour DavidEVP Chief Operating Officer | Open-market sale · 10b5-1 plan | SELL | $1.02M 56.5K sh | Jun 26, 2026 traded Jun 25, 2026 |
| 14 | Chandhok NikhilChief Product & Tech. Officer | Open-market sale · 10b5-1 plan | SELL | $101K 1,334 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 14 | Seymour DavidEVP Chief Operating Officer | Open-market sale · 10b5-1 plan | SELL | $1.18M 69.3K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 13 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $62K 504 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | Van Tuyl ChristopherChief Legal Officer | Option exercise | M | — 17.8K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 13 | Menu PhilippeChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $28K 5,000 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | Frazier WilliamDirector, Chief Medical Officer | Option exercise | M | $18K 10.0K sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $210K 1,696 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | Hughes AaronDirector | Grant or award | A | — 4,176 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $70K 560 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | DeSimone JillDirector | Option exercise · 10b5-1 plan | M | $447K 3,034 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 13 | Bohnert Christopher HSVP, Chief Financial Officer | Tax withholding | F | $25K 9,205 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 12 | Hancock MarkDirector, Co Fndr; Exec V Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $5.57M 138.1K sh | Jun 26, 2026 traded Jun 25, 2026 |
| 12 | Wierbicki PaulDirector, Chief Legal Officer | Option exercise | M | $74K 6,926 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 12 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $1.28M 5,066 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 12 | Burrows Scott LChief Financial Officer | Option exercise | M | $218K 15.0K sh | Jun 26, 2026 traded Jun 25, 2026 |
| 12 | Hancock MarkDirector, Co Fndr; Exec V Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $2.50M 61.7K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 12 | Leibrock Robert WilliamChief Financial Officer | Disposition to issuer | D | $114K 2,454 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 12 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $158K 504 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 12 | Caldwell Jonathan L.Chief People Officer | Open-market sale · 10b5-1 plan | SELL | $114K 2,851 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 12 | DeSimone JillDirector | Open-market sale · 10b5-1 plan | SELL | $210K 683 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 11 | Islam NayaabSee Remarks | Open-market sale · 10b5-1 plan | SELL | $302K 25.1K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 11 | Daunt JohnEVP, Chief Commercial Officer | Open-market sale · 10b5-1 plan | SELL | $296K 7,539 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 11 | Sakamoto Ryan T.EVP, Chief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $11K 2,978 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 10 | Venker EricPresident & Immunovant CEO | Open-market sale · 10b5-1 plan | SELL | $1.55M 46.2K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 10 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $29K 228 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 10 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $1,521 12 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 9 | Kowalski Jessica PatriciaEVP and GM, Research | Grant or award | A | — 20.0K sh | Jun 26, 2026 traded Jun 25, 2026 |
| 9 | Patrick KristinDirector | Grant or award | A | — 31.7K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 9 | Gilliland Arthur WDirector | Option exercise | M | — 6,250 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 9 | Schmitt PeterDirector | Option exercise | M | — 12.4K sh | Jun 26, 2026 traded Jun 25, 2026 |
| 9 | Ignelzi Troy A.Director | Grant or award | A | — 19.0K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 9 | Francis Robert DavidPres Healthcare Pro. Liability | Disposition to issuer | D | — 11.8K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 9 | Chakravarthy ArthiChief Legal Officer | Tax withholding | F | $13K 2,221 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 9 | Ware Olivia CDirector | Grant or award | A | — 19.0K sh | Jun 26, 2026 traded Jun 26, 2026 |